About Contact Us Careers
Sign In

Autoimmune Disease Drugs Market Size

  • Report ID: 2362
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Autoimmune Disease Drugs Market Size

Autoimmune Disease Treatment Market size was valued at USD 6.63 billion in 2023 and is likely to cross USD 16.98 billion by 2036, registering more than 7.5% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of autoimmune disease treatment is estimated at USD 7.03 billion.

Autoimmune Disease Drugs Market
Get more information on this report: Request Free Sample PDF
Browse Key Market Insights with Data Illustration:

Author Credits:  Radhika Pawar


  • Report ID: 2362
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Improvements in government regulations for drug approval procedures that result in higher number of drugs in the market is a major factor that is driving the growth of the market.

The market is anticipated to attain a CAGR of 5% over the forecast period, i.e. 2020-2028.

Significantly improving healthcare infrastructure and development of better treatment facilities in Asia Pacific region are anticipated to provide more business opportunities for the growth of the market in the future.

The major players in the market are Abbott Laboratories, Pfizer, AbbVie, Eli Lilly, Bristol-Myers Squibb, AstraZeneca plc, GlaxoSmithKline, F. Hoffmann-La Roche Ltd., Biogen and Amgen.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample